Pancreatic Neuroendocrine Tumors Treatment in Turkey
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What are Pancreatic Neuroendocrine Tumors?
Pancreatic neuroendocrine tumours (PNETs) represent a rare group of tumours arising from the neuroendocrine cells of the pancreas that produce hormones, including insulin, glucagon, somatostatin, etc. These tumours may be benign or malignant; they usually grow more slowly than other pancreatic tumours, most notably pancreatic adenocarcinoma.
What is the Importance of Timely Treatment?
- Improved Prognosis: The chances of curing or controlling the disease are substantially better with treatment when detected early, including surgical tumour removal. Early interventions lead to long-term survival in localised tumours.
- Preventing Complications: PNETs can lead to complications like hormonal imbalances (e.g., hypoglycemia in insulinomas), pain, or jaundice. Prompt intervention treats the tumours to relieve symptoms and prevent serious complications.
- Reduced Risk of Metastasis: Early diagnosis increases the possibility of metastasis to some distant organs. However, timely therapy can prevent the tumour from progressing and spreading to various organs like the liver.
- Better Life: Early treatments will help control symptoms, pain, and discomfort caused by more extensive or invasive tumours.
What are the Common Symptoms of Pancreatic Neuroendocrine Tumors?
- Hypoglycemia (Low Blood Sugar)
- Hyperglycemia (High Blood Sugar) or Diabetes
- Abdominal Pain
- Unexplained Weight Loss
- Jaundice
- Nausea and Vomiting
- Fatigue
- Palpitations or Rapid Heartbeat
Causes and Risk Factors of Pancreatic Neuroendocrine Tumors
Causes
- Genetic Mutations
- Endocrine Disruptions
- Sporadic Development
Risk Factors
- Genetic Syndromes
- Age
- Family History
- Hormonal Imbalances
- Environmental Factors
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Pancreatic Neuroendocrine Tumors in Turkey
Novel approaches to treating pancreatic neuroendocrine tumors (PNET) are now directed towards precision medicine and targeted therapeutic avenues. Peptide receptor radionuclide therapy (PRRT) has paved the way for one of the most innovative breakthroughs, providing targeted radiation to tumor cells. Next-gen sequencing enables personalised treatment by revealing the presence of specific mutations in patients. Minimally invasive robotic and laparoscopic surgery programs lead to quicker recovery with better outcomes. Immunotherapy and targeted agents such as everolimus and sunitinib are used to slow the growth of tumors.
Pancreatic Neuroendocrine Tumors Prevention Tip:
- Genetic Counseling and Screening: Normal screening and genetic counselling are preventive measures in the timely diagnosis of PNETs for people with a familial history of genetic syndromes, such as MEN1 or von Hippel-Lindau disease.
- Healthy lifestyle choices: Consume a healthy, balanced diet full of fresh fruits, vegetables and whole grains while reducing the levels of processed foods and red meat.
- Avoid Smoking: Smoking is a known carcinogen in most cancers, including the pancreatic types and possibly the PNETs.
- Confirming early detection for high-risk individuals: Individuals with a familial history of endocrine tumours are offered, subject to regular imaging and blood tests to check for possible tumours.
- Management of chronic pancreatitis: Chronic pancreatitis can be managed effectively by medical treatment as it prevents possible PNET development.
Treatment options for Pancreatic Neuroendocrine Tumors
The medical treatment for Pancreatic Neuroendocrine Tumors requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgical Resection: Surgical tumour removal is the most effective treatment option for localised PNETs. Thus, surgery provides the best chance of cure or long-term control in the case of a tumour localised to the pancreas.
Targeted Therapy : Targeted therapies inhibit tumour growth in advanced-stage or metastatic PNET cases. These therapies help slow down disease progression and enhance survival.
Cost Start From USD 7500 - USD 12000Explore Options
Chemotherapy: Chemotherapy with medications is used in aggressive or metastatic PNETs. Chemotherapy is most often used when surgery or targeted therapy proves ineffectual in curbing the disease.
Cost Start From USD 7420 - USD 30000Explore Options
Whipple Procedure (Pancreaticoduodenectomy) : This procedure is performed for localised and resectable tumours. It is intended for functional or non-functional PNETs localised within the pancreas.
Cost Start From USD 15000 - USD 27500Explore Options
Stereotactic Radiotherapy (SRT) is the treatment modality for localised, inoperable, or metastatic PNETs when surgery is not performed. It is also for patients who cannot undergo surgery or whose disease has already spread to other sites.
Cost Start From USD 3750 - USD 5500Explore Options
CyberKnife : The CyberKnife system is typically beneficial in managing small to medium-sized tumours that have proven inoperable, are subject to difficult surgical excision, or have metastasised into surrounding organs or tissue planes.
Cost Start From USD 6520 - USD 9500Explore Options
Proton Therapy : Proton therapy is for such out-of-sight or inoperable PNETs. Given its significance in tumours near critical structures such as blood vessels or the spine, it is also applicable in treatment for metastatic PNETs when the cancer has spread elsewhere.
Cost Start From USD 50000 - USD 65000Explore Options
These are the standard diagnostic methods for diagnosing Pancreatic Neuroendocrine Tumors:
Imaging Studies
- CT Scan: This is one of the most common imaging techniques used for PNET detection, i.e. determining tumour size, location, and evidence of metastasis, if any, especially to the liver or lymph nodes.
- MRI: Generates high-definition images of the pancreas, particularly for delineating soft tissue, and assesses the extent of the tumour.
- Endoscopic Ultrasound: Provides even better imaging for the pancreas and surrounding structures and allows guidance for fine-needle aspiration (FNA) to acquire biopsy samples.
- Positron Emission Tomography: It plays a vital role in tracking a radioactive glucose analogue to locate areas of high metabolic activity associated with malignant tumours.
Biopsy
- Fine Needle Aspiration: Fine needle aspiration techniques, usually done following some imaging modality that indicates tumour presence, are said to be concurrent with an essential ultrasound study, during which tissue samples are taken for histopathological examination, thus confirming the diagnosis of PNETs.
- Core Needle Biopsy: If the need for a more definitive diagnosis arises, it is hence possible for a small core needle biopsy to be performed to gain a tissue sample.
Blood Tests
- Tumour Markers: Serum tumour markers such as chromogranin A (CgA) and pancreatic polypeptide (PP) can be other means for the blood work to diagnose PNETs; elevated levels would strongly suggest the presence of neuroendocrine tumours in the patient.
Somatostatin Receptor Scintigraphy (SRS)
- Octreotide Scan: This technique uses radioactive tracers bound to somatostatin to detect somatostatin receptors on neuroendocrine tumour cells. Generally, this will be applicable in detecting localised, nonmetastatic PNETs amenable to surgical intervention.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
- Rehabilitation following Surgery: Postoperative rehabilitation aims to help patients return to their daily lives after surgical tumour excision by regaining strength and improving mobility.
- Lifestyle modification: Nutritional counselling is a must for patients, especially after surgery to the pancreas, since they will experience some digestive problems due to the diminished function of the pancreas.
- Pain Management: For those who experience pain after treatment, especially surgery or chemotherapeutic agents, it will be helpful to return to pain management therapy after these therapies.
- Hormone and Endocrine Therapy: Patients with functional PNETs (producing excess hormones) may require, in addition to handling symptoms of hypoglycemia, gastric issues, etc., some sort of hormonal therapy to manage their symptoms.
- Psychosocial Support: A diagnosis of cancer creates a stir in the mind and soul of a patient. Counselling, support groups or any form of mental help assists patients and families in bearing the emotional aspects of this disease, PNET.
Instantly Connect with our Specialists
Hospitals for Pancreatic Neuroendocrine Tumors in Turkey
Medical Park Bahcelievler Hospital
Istanbul, Turkey
Medical Park Bahcelievler Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Covers an area of 33.000 m
- 19-storey Hospital Building
- Capacity for 242 beds
- 89 Outpatient clinic rooms
- 10 Operating rooms
- 24 Newborn Incubators
- 6 Paediatric Intensive Care Beds
- 28 Adult Intensive Care beds
- 6 CVS and 12 cardiology intensive care beds
- Luxurious & comfortable rooms like of 5-star hotel rooms for patients
- Free Wi-fi
- Parking lot
- Place of worship
- Cafe/Restaurant
Medical Park Fatih Hospital
Istanbul, Turkey
Medical Park Fatih Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Situated in an area of 6500 m2
- Capacity of 84 beds
- Emergency Clinic
- ICU
- Many special services, including but not limited to T.V. (all domestic and international canals are available), Internet, patient-specific diet and journals and newspapers, are offered to patients to maximize satisfaction
- Private rooms for patients available
- Family accommodation
- Pharmacy
- Laundry
- Mobility accessible rooms
- Parking lot
- Prayer Room
- Cafeteria
Medical Park Canakkale Hospital
Canakkale, Turkey
Apart from in-detail treatment procedures available, Medical Park Canakkale Hospital located in Canakkale, Turkey has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:
- 32 patient rooms
- 2 Operating rooms
- 75 bed capacity
- 24*7 Emergency Service
- Fully equipped Neonatal Care Unit (6 Incubators)
- In-house Pharmacy
- Luxurious rooms for patients designed in such a way that they will feel like at 5-star hotel
- Nurse-call system in rooms
- Cafeteria/Restaurant
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Turkey for Pancreatic Neuroendocrine Tumor Treatment?
The following are the growing reasons for Turkey being frequented for Pancreatic Neuroendocrine Tumor treatment:
World-class cancer center in Turkey because it has modern hospitals and a very competent oncologist.
Innovative treatment modalities: PRRT, target therapy, and robotic surgery have been provided in place for possibly effective treatment.
Affordable Quality Care: Turkey has treatments specialised in cancer therapy at a fraction of what such conditions would cost a patient anywhere in the Western world.
Internationally Recognized Hospitals: JCI-accredited medical centers are ensured to have quality treatment and safety for their patients.
Comprehensive Patient Care: Patients from outside the country will have complete assistance and an assistance program, including travel and accommodation.
Frequently Asked Questions
The prognosis of PNETs is based on the tumour's size, location, and functional status, as well as the presence of metastases. Early detection and surgery are the best options for offering a good prognosis, whereas therapies must be combined with advanced or metastatic cases for managing PNETs.
Most PNETs are sporadic, although they can be combined with some genetic conditions, such as MEN1 syndrome and von Hippel-Lindau disease. Individuals with family histories of these conditions might require genetic counselling and regular screening.
Currently, there is no known preventive measure against PNETs. Yet, a healthy lifestyle that avoids smoking and genetic screening for higher-risk individuals can contribute to early detection and improved management of the disease.
Long-term effects will depend on the treatment method used. Surgical recovery can cause digestive problems, chemotherapy has intermediate side effects such as nausea and lethargy, and targeted therapies can cause skin rashes or fatigue. Monitoring for recurrence or complications must be ensured by regular follow-up care.
Even after treatment, the PNETs can recur depending on whether the tumour was removed entirely or metastasised. Regular follow-up scans and monitoring are very crucial to detect recurrences at an early stage.
A nutritious diet, physical exercise, and abstinence from alcoholic beverages and smoking may enhance a patient's health. Hormone-secreting tumours may also require an individual to follow directed medical advice in managing portions of low blood sugar or digestive issues.
Peptide receptor radionuclide therapy (PRRT) is a targeted nuclear medicine treatment available in Turkey.
Yes, surgeries in robotic and laparoscopic procedures are practiced primarily for faster recovery.
The duration of treatment varies according to tumor type and stage but usually lasts several weeks to several months.
In Turkey, specialised centers are looking into international patients seeking comprehensive care.